Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Celgene Corp (CELG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 95,114,608
  • Shares Outstanding, K 777,970
  • Annual Sales, $ 11,229 M
  • Annual Income, $ 1,999 M
  • 36-Month Beta 1.78
  • Price/Sales 8.54
  • Price/Cash Flow 20.47
  • Price/Book 14.48

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.71 +0.45%
on 04/21/17
126.66 -3.47%
on 04/05/17
-1.56 (-1.26%)
since 03/21/17
3-Month
111.06 +10.08%
on 01/26/17
127.64 -4.21%
on 03/17/17
+9.60 (+8.52%)
since 01/20/17
52-Week
94.42 +29.49%
on 06/27/16
127.64 -4.21%
on 03/17/17
+12.34 (+11.23%)
since 04/21/16

Most Recent Stories

More News
Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback

Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.

CELG : 122.26 (-0.82%)
VRTX : 116.70 (-0.48%)
OMED : 3.73 (-1.84%)
INCY : 123.01 (-0.08%)
GERN : 2.38 (-1.65%)
GILD : 65.93 (-0.86%)
REGN : 370.12 (-1.67%)
OncoMed Cancer Candidate Fails Trial, Bayer Opts Out of Deal

It was a bad day for OncoMed Pharmaceuticals, Inc. (OMED) as it suffered two setbacks.

HSKA : 105.17 (+0.42%)
BAYRY : 113.1000 (+0.93%)
CELG : 122.26 (-0.82%)
OMED : 3.73 (-1.84%)
The Zacks Analyst Blog Highlights: Amazon, Celgene, Facebook and Walgreens Boots

The Zacks Analyst Blog Highlights: Amazon, Celgene, Facebook and Walgreens Boots

CELG : 122.26 (-0.82%)
WBA : 84.03 (-0.13%)
FB : 143.68 (-0.08%)
AMZN : 898.53 (-0.39%)
Top Research Reports for Today: AMZN, CELG, FB, WBA

Top Research Reports for Today: AMZN, CELG, FB, WBA

DD : 78.65 (+0.46%)
CELG : 122.26 (-0.82%)
FOXA : 30.70 (-1.19%)
QCOM : 52.50 (-0.30%)
WBA : 84.03 (-0.13%)
FB : 143.68 (-0.08%)
AMZN : 898.53 (-0.39%)
Today's Research Reports on Top Biotech Stocks: Gilead Sciences and Celgene

NEW YORK, NY / ACCESSWIRE / April 7, 2017 / The major products of both companies could suffer a drop in revenues from recent political events and competition from generic versions of their drugs.

CELG : 122.26 (-0.82%)
GILD : 65.93 (-0.86%)
Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst

Celgene Corporation (CELG) recently received a Paragraph IV Notice Letter advising that Teva Pharmaceutical Industries Limited (TEVA) submitted an ANDA to the FDA seeking an approval to manufacture and...

HSKA : 105.17 (+0.42%)
CELG : 122.26 (-0.82%)
TEVA : 31.13 (+1.20%)
RTRX : 18.47 (-1.96%)
Look for Shares of Celgene to Potentially Pullback after Yesterday's 1.06% Rise

Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $124.45 to a high of $126.66. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $125.69...

CELG : 122.26 (-0.82%)
Celgene Set to Possibly Pullback After Yesterday's Rally of 1.06%

Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $124.45 to a high of $126.66. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $125.69...

CELG : 122.26 (-0.82%)
Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug

Court rulings and patent challenges made headlines in the biotech sector with companies like Acorda (ACOR) and Celgene (CELG) providing updates.

CELG : 122.26 (-0.82%)
VRTX : 116.70 (-0.48%)
GILD : 65.93 (-0.86%)
ACOR : 15.85 (-0.63%)
KITE : 79.50 (-2.03%)
PRTK : 22.00 (+1.85%)
AMGN : 160.41 (-1.01%)
Celgene Notified of ANDA Filing for POMALYST(R)

Celgene Corporation (NASDAQ:CELG) has received a Paragraph IV Notice Letter advising that Teva Pharmaceuticals USA, Inc. submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food...

CELG : 122.26 (-0.82%)
CELGZ : 1.10 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

See More

Support & Resistance

2nd Resistance Point 124.65
1st Resistance Point 123.46
Last Price 122.26
1st Support Level 121.39
2nd Support Level 120.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.